Adjuvant management of operated uterine sarcomas: A single institution experience
  • Clinic

Adjuvant management of operated uterine sarcomas: A single institution experience

Outcomes of the use of different vulvar flaps for reconstruction during surgery for vulvar cancer
  • Clinic

Outcomes of the use of different vulvar flaps for reconstruction during surgery for vulvar cancer

Mapping Spatiotemporal Microproteomics Landscape in Experimental Model of Traumatic Brain Injury Unveils a link to Parkinson’s Disease
  • Recherche

Mapping Spatiotemporal Microproteomics Landscape in Experimental Model of Traumatic Brain Injury Unveils a link to Parkinson’s Disease

Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases
  • Clinic

Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases

OpenProt: a more comprehensive guide to explore eukaryotic coding potential and proteomes
  • Recherche

OpenProt: a more comprehensive guide to explore eukaryotic coding potential and proteomes

High-field intraoperative MRI and glioma surgery: results after the first 100 consecutive patients
  • Clinic

High-field intraoperative MRI and glioma surgery: results after the first 100 consecutive patients

Immunotherapy for glioblastoma: quo vadis?
  • Clinic

Immunotherapy for glioblastoma: quo vadis?

Evaluation of serum thymidine kinase 1 activity as a biomarker for treatment effectiveness and prediction of relapse in dogs with non-Hodgkin lymphoma
  • Recherche

Evaluation of serum thymidine kinase 1 activity as a biomarker for treatment effectiveness and prediction of relapse in dogs with non-Hodgkin lymphoma

Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
  • Clinic

Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial
  • Clinic

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

How we treat glioblastoma
  • Clinic

How we treat glioblastoma

PET imaging in patients with brain metastasis-report of the RANO/PET group
  • Clinic

PET imaging in patients with brain metastasis-report of the RANO/PET group